Glutathione injections: evidence, safety and costs

Glutathione is one of the most common add-ons at IV lounges and longevity telehealth companies. It is sold as a detox, an energy boost and a skin brightener. The research behind it is thinner than the marketing, and most of it tested glutathione taken by mouth or put on the skin. The bigger story in 2026 is safety: FDA has now warned twice that sterile glutathione injections were made from powder meant for supplements ^{[2] [1]}. This page covers what glutathione is, what the trials found, what FDA said and what it costs through a prescriber.

Glutathione is an antioxidant your body already makes

Your cells make glutathione from three amino acids: glutamate, cysteine and glycine. It soaks up reactive oxygen, helps the liver process some drugs and toxins, and supports immune cells. Levels fall with some illnesses, and that observation is where the supplement and drip market started.

Making more glutathione available is not the same as making a person healthier. The question that matters is whether taking it, by mouth, on the skin or by vein, changes anything you would notice or a doctor could measure. That is what the trials below test.

What the trials show: small, short and mostly oral

Glutathione's human trials are small, short and mostly used pills or creams, not injections. Selected results illustrate the differences, and each comes with a limit worth knowing.

• Body stores (Richie 2015). 54 healthy non-smoking adults took oral glutathione or placebo for 6 months. In the higher-dose group, glutathione in red cells, plasma and lymphocytes rose 30% to 35%, and levels returned to baseline a month after stopping ^[5]. It shows measured body stores can rise; it does not establish that intact glutathione reaches tissues unchanged. It does not show a health outcome.
• Insulin sensitivity (Søndergård 2021). 20 men with obesity, half with type 2 diabetes, took oral glutathione or placebo for 3 weeks. Whole-body insulin sensitivity rose in the glutathione group, but oxidative-stress markers did not change ^[6].
• Skin tone (Wahab 2021). 46 people used topical and oral glutathione in a split-face design for 8 weeks. The combination group had a lower melanin index than placebo ^[7].
• The skin-lightening review (Sonthalia 2018). Dermatologists reviewing the field found the evidence for IV glutathione as a skin lightener "limited to a single study with a dubious study design" ^[8].

Injections vs pills vs creams: what has been tested

A 2015 randomized safety/tolerability trial enrolled 30 people with Parkinson’s disease and found no substantial group differences in the safety measures assessed over 3 months ^[9]. A later 45-person double-blind trial found improvements from baseline in all groups, including placebo; neither active group was superior. One active-group participant developed cardiomyopathy, with uncertain causality. These findings do not establish disease modification, a generally safe nasal product or wellness benefits in healthy users ^[10].

Evidence must be separated by route and population. Oral and topical cosmetic studies cannot establish an IV skin-lightening effect. The 2018 review describes the IV cosmetic evidence it assessed as a single methodologically weak study; that is a dated review finding, not an exhaustive current claim about every clinical use ^[8]. Nasal studies in Parkinson’s disease also exist, but they do not establish healthy-person wellness benefits ^{[9] [10]}.

A route that raises a laboratory biomarker does not necessarily improve symptoms or function. Differences in formulation, absorption, population and outcome measures prevent substituting oral or nasal findings for evidence on an injected wellness product.

Safety: FDA's 2019 and 2026 warnings

Both FDA alerts trace patient reactions to supplement-grade glutathione used to make sterile injections. Powder made for capsules is not made to the purity a vein needs. When it carries bacterial endotoxin, a fever-causing residue from bacteria, the result can look like a serious infection.

2019. FDA warned compounders on February 1, 2019 not to use L-glutathione powder repackaged by Letco Medical of Decatur, Alabama, for sterile injections. It had a report of seven patients at one clinic who developed nausea, vomiting, chills and body aches within minutes of an IV dose; one was hospitalized. A second report described another patient admitted with a possible bloodstream infection. The powder came from a foreign maker that sold it only for supplements. "All samples tested by an FDA laboratory were found to contain excessive bacterial endotoxin," some at five times the limit ^[2].

2026. On August 27, 2026, FDA said it was aware of "at least 30 patients who experienced adverse events" after IV glutathione, alone or mixed with other ingredients ^[1]. Different pharmacies had made the drips, all from lot #229536 of supplement-grade glutathione from Medisca, an ingredient supplier. Two Texas pharmacies recalled glutathione injections for high endotoxin levels. Reactions included fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms, with some hospitalizations. FDA said it "continues to receive reports" and is "actively investigating" ^[1].

These FDA alerts establish serious product-quality concerns; they do not establish that contamination is the only possible risk or that glutathione itself is harmless. Small studies cannot exclude uncommon or delayed effects. The nasal Parkinson trial reported one cardiomyopathy event with uncertain treatment relationship ^[10]. The parallel NAD+ injection safety guide explains why route and manufacturing quality also matter there.

FDA status: why pharmacies can compound it

FDA lists glutathione in Category 1, meaning it remains under evaluation. The interim enforcement policy applies only when all its conditions and other applicable requirements are met; the entry is not FDA approval of a compounded product or blanket eligibility for every route and formulation ^[3].

The approved BSS PLUS eye-irrigation label names glutathione disulfide, the oxidized form, among its ingredients. The product is for irrigation during ophthalmic surgery, not injection or IV infusion ^[4]. That formulation and use do not approve reduced-glutathione wellness injections.

Compare the complete offer before paying

The glutathione provider board compares the available records and shows prices only where the selected plan can be normalized. A starting amount, a first-month promotion or a vial supply duration is not enough to establish a recurring calendar-month cost. Read the actual offer and obtain a written quote for the product you would receive.

For product-specific terms, see AgelessRx, HealthRX and Belle. Confirm the route, total due now, exact charge interval, supply duration, consultation and lab charges, renewal price and cancellation cutoff. The peptide cost guide explains how to compare those figures without treating an introductory amount as a standing bill.

Before you start: what to ask the prescriber

The questions that matter most come straight from FDA's two alerts. Ask them before the first vial or drip, and get the answers in writing.

1. Which pharmacy compounds it, and is it a state-licensed 503A pharmacy?
2. Is the glutathione pharmaceutical grade, made for injectable drugs, rather than dietary-supplement grade? FDA's 2026 alert turned on exactly this ^[1].
3. What ingredient-sourcing, preparation, sterility and endotoxin controls apply? FDA cautions that testing alone cannot ensure quality ^[1].
4. What would you want me to watch for after a dose, and who do I call?
5. What is the monthly total once any intro price ends?

Reactions after a compounded injection can be reported to FDA's MedWatch program, which is how both alerts started ^[1]. For how this site rates the pharmacy, pricing and support behind each provider, see how we check.

How glutathione compares with other drips and peptides

Glutathione often shares a menu with NAD+. FDA lists both in conditional Category 1, but their clinical evidence and formulations differ ^[3]. Neither a shared pathway nor a biomarker rise establishes anti-aging benefit in healthy people. The NAD+ IV guide reviews that route separately.

Skin buyers also see glutathione next to GHK-Cu, a copper peptide. GHK-Cu is a skin-care ingredient used on the skin, while glutathione is an antioxidant sold as drips, pills and creams. They answer different questions.

Terms used on this page